SEC Form 4 · accession 0001387131-15-000429
Ohr Pharmaceutical Inc · OHRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
June Sherie Almenoff
Director
Period of report
Feb 6, 2015
Accepted (ET)
Feb 10, 2015 · 12:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001173281
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | Feb 6, 2015 | P | 6,000 | $6.75 | A | 16,900 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionF1 | $4.68 | holding | — | — | — | May 17, 2013 | May 17, 2018 | Common Stock | 116,667 | 116,667 | D |
Explanation of responses
- F158,333 options are currently unexercisable; half will become exercisable on May 17, 2015 and half will become exercisable on May 17, 2016.